Cesar A. Arias, MD, MSc, PhD

Professor
University of Texas Health Science Center
Houston, TX

Cesar A. Arias, MD. MSc, PhD. is Professor of Medicine, Microbiology and Molecular Genetics at University of Texas Health Science Center (UTHealth), Houston. He holds the Margaret and Herbert Dupont Chair in Infectious Diseases and the Laurel and Robert H. Graham Faculty Fellowship at UTHealth. He is the founder director of the Center for Antimicrobial Resistance and Microbial Genomics (CARMiG) at McGovern Medical School and the Center for Infectious Diseases at the UTHealth School of Public Health. Dr. Arias obtained his MD from Universidad El Bosque, Bogota, Colombia, MSc in Clinical Microbiology from University of London and a PhD in Molecular Microbiology from University of Cambridge, UK. As a Wellcome Trust International Fellow, he founded (and still directs) the Molecular Genetics and Antimicrobial Resistance Unit and International Center for Microbial Genomics at Universidad El Bosque, Bogota. In 2002, he moved to Houston for Internal Medicine and ID training at UTHealth McGovern Medical School and UT MD Anderson Cancer Center. He joined the UTHealth faculty as assistant professor in 2008 and became professor in 2016. Dr. Arias is a nationally and internationally recognized expert conducting basic, translational and clinical research on antibiotic resistance. He was one of the first recipients of the NIH K99/R00 Pathway to Independence Award and received the ASM Young Investigator Award and the IDSA Oswald Avery Award for early achievement. He was inducted to the American Society of Clinical Investigation in 2015 and the American Academy of Microbiology in 2019 and serves as editor of Antimicrobial Agents and Chemotherapy and IDSA Chair of IDWeek 2019.

Disclosure: American Society for Microbiology: Fees for Editor of Antimicrobial Agents and Chemotherapy. Money paid to University, Other Financial or Material Support
Entasis Pharmaceuticals: Grant/Research Support, Research Grant
MeMed Diagnostics: Grant/Research Support, Research Grant
Merck: Grant/Research Support, Research Grant
UptoDate: Other Financial or Material Support, Royalties from a Chapter

Presentation(s):

• 7 - What's Hot in ID + HIV

  Wednesday, October 2
  1:30 PM – 3:15 PM

• 8 - Opening Plenary Session: From Outbreaks to -Omics: Revolutionizing the Infectious Diseases Landscape in the Age of Big Data

  Wednesday, October 2
  3:45 PM – 5:15 PM

• 19 - Edward H. Kass Lecture

  Thursday, October 3
  9:15 AM – 10:00 AM

• 99 - The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)

  Thursday, October 3
  12:40 PM – 12:45 PM

• 76 - Head Scratching Cases of MDR Gram-Negatives Other than Enterobacteriales

  Thursday, October 3
  1:45 PM – 3:00 PM

• 903 - IDSA Featured Oral Abstract: Resensitization to ß-lactams in Enterococci Depends on Penicillin-Binding Protein (PBP) Mislocalization and Is Mediated by a Single Protein That Modulates Cell Membrane (CM) Adaptation to Daptomycin (DAP)

  Thursday, October 3
  5:05 PM – 5:20 PM

• 118 - Phages to the Rescue

  Friday, October 4
  10:30 AM – 11:45 AM

• 1827 - Genetic Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Associated with the Development of Reduced Susceptibility to Vancomycin from Latin America

  Friday, October 4
  2:15 PM – 2:30 PM

• 210 - Registration Trials versus Clinical Practice: Challenges Associated with Newly Approved Antimicrobials

  Saturday, October 5
  8:00 AM – 9:00 AM

• 317 - Closing Plenary Session: All About Vaccines: The Individual, the Community, the World

  Sunday, October 6
  9:15 AM – 10:45 AM